SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the <i>N</i>-glycolyl GM3-specific anti-tumor antibody 14F7.

Bousquet, Paula A; Manna, Dipankar; Sandvik, Joe A; Arntzen, Magnus Ø; Moreno, Ernesto; Sandvig, Kirsten; Krengel, Ute

SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the N-glycolyl GM3-specific anti-tumor antibody 14F7.

Bousquet, Paula A; Manna, Dipankar; Sandvik, Joe A; Arntzen, Magnus Ø; Moreno, Ernesto; Sandvig, Kirsten; Krengel, Ute.

Afiliación

Bousquet PA; Department of Chemistry, University of Oslo, Oslo, Norway.
Manna D; Department of Chemistry, University of Oslo, Oslo, Norway.
Sandvik JA; Department of Physics, University of Oslo, Oslo, Norway.
Arntzen MØ; Department of Biosciences, University of Oslo, Oslo, Norway.
Moreno E; Facultad de Ciencias Básicas, Universidad de Medellín, Medellín, Colombia.
Sandvig K; Department of Biosciences, University of Oslo, Oslo, Norway.
Krengel U; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway.

Front Immunol ; 13: 994790, 2022.

Article en En | MEDLINE | ID: mdl-36439103

Asunto(s)

Neoplasias; Proteómica; Humanos; Células HeLa; Microscopía; Anticuerpos Monoclonales

Palabras clave

14F7; NeuGc GM3/Neu5Gc GM3; SILAC; cytoskeleton; ganglioside; glycosphingolipid; immunotherapy; transcription factors

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteómica / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google